Literature DB >> 11037921

Anterior uveitis following combined vaccination for measles, mumps and rubella (MMR): a report of two cases.

S M Islam1, H F El-Sheikh, K F Tabbara.   

Abstract

PURPOSE: To describe two children who developed anterior uveitis after vaccination for common childhood diseases.
METHODS: A retrospective study of two Saudi patients who were seen at The Eye Center, Riyadh, Saudi Arabia.
RESULTS: Aged 12 and 14, respectively, the two patients developed anterior non-granulomatous uveitis 6 and 4 weeks after having the combined vaccination for measles, mumps and rubella (MMR). No other definite cause of uveitis was detected from history or from laboratory work up. Both patients responded to traditional regimens of uveitis therapy. However, they required a treatment period of several months.
CONCLUSION: Anterior uveitis may occur following MMR vaccination. Cases of vaccination thus require ophthalmic awareness if visual symptoms or a painful red eye develop.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11037921     DOI: 10.1034/j.1600-0420.2000.078005590.x

Source DB:  PubMed          Journal:  Acta Ophthalmol Scand        ISSN: 1395-3907


  8 in total

1.  Acute unilateral conjunctivitis after rubella vaccination: the detection of the rubella genome in the inflamed conjunctiva by reverse transcriptase-polymerase-chain reaction.

Authors:  N Kitaichi; T Ariga; S Ohno; T Shimizu
Journal:  Br J Ophthalmol       Date:  2006-11       Impact factor: 4.638

Review 2.  [Adverse ocular effects of vaccinations].

Authors:  T Ness; H Hengel
Journal:  Ophthalmologe       Date:  2016-07       Impact factor: 1.059

3.  Acute Bilateral Photoreceptor Degeneration in an Infant After Vaccination Against Measles and Rubella.

Authors:  Kazuki Kuniyoshi; Yoshikazu Hatsukawa; Sadami Kimura; Takahiro Fujino; Hiroshi Ohguro; Rie Nakai; Kenta Sunami; So-Ichiro Mishima; Tomoko Sato; Shunji Kusaka; Yasuhiro Suzuki; Yoshikazu Shimomura
Journal:  JAMA Ophthalmol       Date:  2017-05-01       Impact factor: 7.389

4.  Rubella persistence in epidermal keratinocytes and granuloma M2 macrophages in patients with primary immunodeficiencies.

Authors:  Ludmila Perelygina; Stanley Plotkin; Pierre Russo; Timo Hautala; Francisco Bonilla; Hans D Ochs; Avni Joshi; John Routes; Kiran Patel; Claudia Wehr; Joseph Icenogle; Kathleen E Sullivan
Journal:  J Allergy Clin Immunol       Date:  2016-09-06       Impact factor: 10.793

5.  Vaccine-Associated Uveitis.

Authors:  Matthew Benage; Frederick W Fraunfelder
Journal:  Mo Med       Date:  2016 Jan-Feb

6.  High concordance of intraocular antibody synthesis against the rubella virus and Fuchs heterochromic uveitis syndrome in Slovenia.

Authors:  Spela Stunf; Miroslav Petrovec; Nina Žigon; Marko Hawlina; Aleksandra Kraut; Jolanda D F de Groot-Mijnes; Nataša Vidovič Valentinčič
Journal:  Mol Vis       Date:  2012-12-01       Impact factor: 2.367

7.  Drug-induced uveitis.

Authors:  Nikolas Js London; Sunir J Garg; Ramana S Moorthy; Emmett T Cunningham
Journal:  J Ophthalmic Inflamm Infect       Date:  2013-03-25

8.  Infectious vaccine-derived rubella viruses emerge, persist, and evolve in cutaneous granulomas of children with primary immunodeficiencies.

Authors:  Ludmila Perelygina; Min-Hsin Chen; Suganthi Suppiah; Adebola Adebayo; Emily Abernathy; Morna Dorsey; Lionel Bercovitch; Kenneth Paris; Kevin P White; Alfons Krol; Julie Dhossche; Ivan Y Torshin; Natalie Saini; Leszek J Klimczak; Dmitry A Gordenin; Andrey Zharkikh; Stanley Plotkin; Kathleen E Sullivan; Joseph Icenogle
Journal:  PLoS Pathog       Date:  2019-10-28       Impact factor: 6.823

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.